CORMEDIX INC. - COMMON STOCK
9.1200
29-April-25 15:45:00
15 minutes delayed
Stocks
+0.0600
+0.66%
Today's range
8.9373 - 9.1900
ISIN
N/A
Source
NASDAQ
-
CorMedix Inc. Receives FDA Feedback on Potential Label Expansion
18 Jun 2024 07:00:00 By Nasdaq GlobeNewswire
-
CorMedix Inc. Announces CMS Grants Pass-Through Status to Defencath
06 Jun 2024 07:30:00 By Nasdaq GlobeNewswire
-
CorMedix Inc. to Participate in Two Upcoming Investor Conferences
10 May 2024 07:30:00 By Nasdaq GlobeNewswire
-
CorMedix Inc. Reports First Quarter 2024 Financial Results and Provides Business Update
09 May 2024 06:30:00 By Nasdaq GlobeNewswire
-
06 May 2024 07:30:00 By Nasdaq GlobeNewswire
-
CorMedix Inc. Announces CMS Grants TDAPA to DefenCath
19 Apr 2024 07:30:00 By Nasdaq GlobeNewswire
-
15 Apr 2024 07:30:00 By Nasdaq GlobeNewswire
-
11 Apr 2024 07:30:00 By Nasdaq GlobeNewswire
-
CorMedix Inc. Announces Commercial Agreement With ARC Dialysis, LLC
08 Apr 2024 07:30:00 By Nasdaq GlobeNewswire
-
CorMedix Inc. to Present at the Needham Annual Healthcare Conference
27 Mar 2024 07:30:00 By Nasdaq GlobeNewswire
-
12 Mar 2024 06:30:00 By Nasdaq GlobeNewswire
-
06 Mar 2024 07:30:00 By Nasdaq GlobeNewswire
-
CorMedix Inc. Announces Commercial and Reimbursement Updates
30 Jan 2024 07:30:00 By Nasdaq GlobeNewswire
-
CorMedix Inc. Announces Commercial and Operational Updates
08 Jan 2024 07:30:00 By Nasdaq GlobeNewswire
-
CorMedix Inc. Announces Appointment of Chief Legal Officer
15 Dec 2023 07:30:00 By Nasdaq GlobeNewswire
-
CorMedix Inc. Announces Partnership With The Leapfrog Group
04 Dec 2023 07:30:00 By Nasdaq GlobeNewswire
-
15 Nov 2023 11:57:47 By Nasdaq GlobeNewswire
-
14 Nov 2023 15:05:00 By Nasdaq GlobeNewswire
-
02 Nov 2023 07:30:00 By Nasdaq GlobeNewswire
-
CorMedix Inc. Announces Abstract Presentation at Upcoming IDWeek Conference
11 Oct 2023 07:30:00 By Nasdaq GlobeNewswire